Shohei Mishima

435 total citations
13 papers, 333 citations indexed

About

Shohei Mishima is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, Shohei Mishima has authored 13 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Shohei Mishima's work include Cannabis and Cannabinoid Research (4 papers), Sleep and Wakefulness Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Shohei Mishima is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Sleep and Wakefulness Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Shohei Mishima collaborates with scholars based in Japan, Austria and United States. Shohei Mishima's co-authors include Michihiro Fujiwara, Kazuhide Hayakawa, Kenichi Mishima, Katsunori Iwasaki, Masayuki Fujioka, Kensuke Orito, Nobuaki Egashira, Mai Hazekawa, Masanori Nozako and Keiichi Irie and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Stroke.

In The Last Decade

Shohei Mishima

12 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shohei Mishima Japan 8 114 106 74 70 51 13 333
Natalie M. Wilson United States 9 92 0.8× 37 0.3× 39 0.5× 151 2.2× 10 0.2× 11 511
Valerie L. Reeves United States 10 34 0.3× 72 0.7× 173 2.3× 25 0.4× 12 0.2× 12 454
Valeria Sasso Italy 9 25 0.2× 140 1.3× 50 0.7× 81 1.2× 19 0.4× 10 357
Gülay Üzüm Türkiye 13 24 0.2× 63 0.6× 40 0.5× 93 1.3× 6 0.1× 22 383
Lisa B. Willing United States 10 11 0.1× 178 1.7× 114 1.5× 68 1.0× 23 0.5× 16 461
K. Sullivan United States 9 25 0.2× 33 0.3× 23 0.3× 86 1.2× 22 0.4× 13 438
Enji Zhang South Korea 11 33 0.3× 75 0.7× 51 0.7× 107 1.5× 13 0.3× 19 388
Yohance M. Allette United States 8 28 0.2× 33 0.3× 15 0.2× 86 1.2× 70 1.4× 11 343
Leigh Wellhauser Canada 14 17 0.1× 41 0.4× 74 1.0× 50 0.7× 10 0.2× 18 647
E. Shohami Israel 6 69 0.6× 58 0.5× 71 1.0× 79 1.1× 3 0.1× 9 341

Countries citing papers authored by Shohei Mishima

Since Specialization
Citations

This map shows the geographic impact of Shohei Mishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shohei Mishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shohei Mishima more than expected).

Fields of papers citing papers by Shohei Mishima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shohei Mishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shohei Mishima. The network helps show where Shohei Mishima may publish in the future.

Co-authorship network of co-authors of Shohei Mishima

This figure shows the co-authorship network connecting the top 25 collaborators of Shohei Mishima. A scholar is included among the top collaborators of Shohei Mishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shohei Mishima. Shohei Mishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Miyamoto, Nobukazu, Yuji Ueno, Kazuo Yamashiro, et al.. (2023). Stroke classification and treatment support system artificial intelligence for usefulness of stroke diagnosis. Frontiers in Neurology. 14. 1295642–1295642. 7 indexed citations
2.
Mishima, Shohei, et al.. (2023). A Case of Small Cell Lung Cancer with COVID-19 Pneumonia During Chemoimmunotherapy. Haigan. 63(1). 27–32.
3.
Mishima, Shohei, et al.. (2022). A Study of the Relationship Between Interstitial Lung Abnormalities and Osimertinib-induced Lung Injury. Haigan. 62(4). 292–298. 1 indexed citations
4.
Mishima, Shohei, et al.. (2022). Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy. Anticancer Research. 42(10). 4805–4812. 3 indexed citations
5.
Masuda, Takeshi, Nobuki Imano, Naoko Matsumoto, et al.. (2022). Pre-existing interstitial lung abnormalities are independent risk factors for interstitial lung disease during durvalumab treatment after chemoradiotherapy in patients with locally advanced non–small lung cancer.. Journal of Clinical Oncology. 40(16_suppl). 8528–8528. 2 indexed citations
6.
Nakamura, Takashi, et al.. (2021). Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors. In Vivo. 35(1). 467–474. 12 indexed citations
7.
8.
Higuchi, Sei, Keiichi Irie, Ryuji Yamaguchi, et al.. (2012). Hypothalamic 2-Arachidonoylglycerol Regulates Multistage Process of High-Fat Diet Preferences. PLoS ONE. 7(6). e38609–e38609. 28 indexed citations
9.
Higuchi, Sei, Keiichi Irie, Shohei Mishima, et al.. (2010). The Cannabinoid 1–Receptor Silent Antagonist O-2050 Attenuates Preference for High-Fat Diet and Activated Astrocytes in Mice. Journal of Pharmacological Sciences. 112(3). 369–372. 21 indexed citations
10.
Hayakawa, Kazuhide, Kenichi Mishima, Keiichi Irie, et al.. (2008). Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism. Neuropharmacology. 55(8). 1280–1286. 76 indexed citations
11.
Hayakawa, Kazuhide, Kenichi Mishima, Masanori Nozako, et al.. (2008). Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1–Inhibiting Mechanism. Stroke. 39(3). 951–958. 122 indexed citations
12.
Hayakawa, Kazuhide, Kenichi Mishima, Masanori Nozako, et al.. (2007). Δ9-tetrahydrocannabinol (Δ9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia. Life Sciences. 80(16). 1466–1471. 25 indexed citations
13.
Ohara, K., Y Fukado, Yoshikazu Uchida, et al.. (1982). [Effects of topical indomethacin on suppression of inflammation after the ocular surgeries--double masked study of anti-inflammatory effects on the intra capsular lens extraction].. PubMed. 86(12). 2198–212. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie M. Wilson Breakdown of academic impact, for papers by Valerie L. Reeves Breakdown of academic impact, for papers by Valeria Sasso Breakdown of academic impact, for papers by Gülay Üzüm Breakdown of academic impact, for papers by Lisa B. Willing Breakdown of academic impact, for papers by K. Sullivan Breakdown of academic impact, for papers by Enji Zhang Breakdown of academic impact, for papers by Yohance M. Allette Breakdown of academic impact, for papers by Leigh Wellhauser Breakdown of academic impact, for papers by E. Shohami
Rankless by CCL
2026